Cutera (NASDAQ:CUTR) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research note released on Monday morning. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Price Performance

Shares of CUTR stock opened at $0.41 on Monday. The firm has a market cap of $8.28 million, a P/E ratio of -0.06 and a beta of 1.31. Cutera has a 1-year low of $0.28 and a 1-year high of $3.73. The firm has a fifty day moving average of $0.39 and a two-hundred day moving average of $0.74.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC grew its stake in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the period. Squarepoint Ops LLC owned about 0.57% of Cutera worth $172,000 at the end of the most recent quarter. Institutional investors and hedge funds own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.